If you’re looking into CertaPet this year, understand what you’re actually buying. The marketing leans heavily on compliance language licensed providers, federal housing law, clinical standards. It reads like a risk-managed healthcare solution. What I experienced felt far closer to a volume-driven document service.

The Evaluation Felt Superficial

The intake process creates the impression of rigor. Detailed forms, carefully worded questions, repeated emphasis on legitimacy. But once I reached the live portion of the assessment, it became clear how thin it really was. There was no serious examination of symptom history, no meaningful probing of alternative treatments, and no real discussion about whether an ESA was clinically appropriate versus simply convenient. At no point did it feel like denial was a realistic possibility. The tone suggested the outcome was already aligned with the transaction. It didn’t feel malicious. It felt engineered for throughput.

A legitimate clinical determination involves uncertainty, professional discretion, and visible reasoning. That complexity was absent. Approval felt assumed rather than earned. ESA documentation tied to housing protections is supposed to reflect independent medical judgment. When the process feels automatic, credibility becomes fragile.

The Letter Looked Polished but Generic

The letter arrived quickly and looked professional. License information was included and the formatting was clean. But the substance was extremely broad. The wording could apply to almost anyone experiencing stress or anxiety. There was no individualized narrative, no depth, nothing that demonstrated careful consideration of a nuanced case. In 2026, landlords are familiar with online ESA platforms. Template-heavy language does not reassure them; it invites scrutiny. Instead of feeling protected, I felt exposed.

Support Declined After Payment

Before payment, communication was fast and confident. After the letter was issued, responsiveness shifted. When I asked what would happen if my landlord challenged the documentation, whether the provider would directly verify the recommendation, and what support existed beyond the letter itself, the answers became vague and procedural. There was no clear commitment to defend the clinical reasoning behind the evaluation. Just general references to compliance. That distinction matters when housing stability is involved.

The Bigger Concern

Speed is not the same as legitimacy. Efficiency is not the same as rigor. If a service is structured to optimize approvals and minimize friction, it may succeed operationally, but that does not mean the evaluation would withstand serious scrutiny if questioned. ESA protections require defensible medical judgment, not just a formatted PDF delivered quickly.

What I received was fast. What I did not receive was confidence that anyone would stand behind it if challenged. If your situation is low-conflict, speed may feel sufficient. If your housing situation is high-stakes or adversarial, relying on a streamlined platform built for scale may carry more risk than the marketing suggests. There is a difference between obtaining a letter and having a provider prepared to justify it. In my experience, this felt like the former and not the latter.